| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DEMANT.CO - | SELL | -2,772 @ DKK 28.4384 | DKK -78,831 | The ETF sold 2772 shares of DEMANT.CO on 2025-12-09. The shares were previously bought for an average price of DKK 32.2794. The shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of DKK 10,647 (USD $1,660) The average price that the ETF previously sold DEMANT.CO share for is DKK 34.3432 which is higher than the selling price of DKK 28.4384 on 2025-12-09. |
| HIK.L - | SELL | -4,851 @ GBP 17.7239 | GBP -85,979 | The ETF sold 4851 shares of HIK.L on 2025-12-09. The shares were previously bought for an average price of GBP 22.3835. The shares were sold for -20.8% lower than average price of previous purchases. This resulted in an overall loss of GBP 22,604 (USD $30,123) The average price that the ETF previously sold HIK.L share for is GBP 23.1831 which is higher than the selling price of GBP 17.7239 on 2025-12-09. |
| GRF.MC - Grifols SA | SELL | -8,613 @ EUR 10.725 | EUR -92,374 | The ETF sold 8613 shares of GRF.MC on 2025-12-09. The shares were previously bought for an average price of EUR 10.6752. The Grifols SA shares were sold for 0.5% higher than average price of previous purchases. This sale made a profit of EUR 429 (USD $500) The average price that the ETF previously sold GRF.MC share for is EUR 10.3647 so the ETF has sold 8613 shares on 2025-12-09 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -1,188 @ EUR 104.4 | EUR -124,027 | The ETF sold 1188 shares of BIM.PA on 2025-12-09. The shares were previously bought for an average price of EUR 114.199. The BioMerieux shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of EUR 11,641 (USD $13,552) The average price that the ETF previously sold BIM.PA share for is EUR 111.473 which is higher than the selling price of EUR 104.4 on 2025-12-09. |
| TUB.BR - Financiere de Tubize SA | SELL | -594 @ EUR 217 | EUR -128,898 | The ETF sold 594 shares of TUB.BR on 2025-12-09. The shares were previously bought for an average price of EUR 210.25. The Financiere de Tubize SA shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of EUR 4,010 (USD $4,668) The average price that the ETF previously sold TUB.BR share for is EUR 220.5 which is higher than the selling price of EUR 217 on 2025-12-09. |
| IPN.PA - Ipsen SA | SELL | -1,089 @ EUR 123.5 | EUR -134,492 | The ETF sold 1089 shares of IPN.PA on 2025-12-09. The shares were previously bought for an average price of EUR 110.554. The Ipsen SA shares were sold for 11.7% higher than average price of previous purchases. This sale made a profit of EUR 14,098 (USD $16,412) The average price that the ETF previously sold IPN.PA share for is EUR 108.196 so the ETF has sold 1089 shares on 2025-12-09 at a higher price than the previous selling average. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -3,333 @ EUR 48.1 | EUR -160,317 | The ETF sold 3333 shares of REC.MI on 2025-12-09. The shares were previously bought for an average price of EUR 52.7383. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for -8.8% lower than average price of previous purchases. This resulted in an overall loss of EUR 15,459 (USD $17,997) The average price that the ETF previously sold REC.MI share for is EUR 51.2653 which is higher than the selling price of EUR 48.1 on 2025-12-09. |
| SOBI.ST - | SELL | -5,709 @ SEK 29.7404 | SEK -169,788 | The ETF sold 5709 shares of SOBI.ST on 2025-12-09. The shares were previously bought for an average price of SEK 26.7864. The shares were sold for 11.0% higher than average price of previous purchases. This sale made a profit of SEK 16,864 (USD $1,795) The average price that the ETF previously sold SOBI.ST share for is SEK 27.3398 so the ETF has sold 5709 shares on 2025-12-09 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -858 @ EUR 208.1 | EUR -178,550 | The ETF sold 858 shares of DIM.PA on 2025-12-09. The shares were previously bought for an average price of EUR 192.964. The Sartorius Stedim Biotech shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of EUR 12,987 (USD $15,118) The average price that the ETF previously sold DIM.PA share for is EUR 191.477 so the ETF has sold 858 shares on 2025-12-09 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -759 @ EUR 249 | EUR -188,991 | The ETF sold 759 shares of SRT3.DE on 2025-12-09. The shares were previously bought for an average price of EUR 217.069. The Sartorius AG shares were sold for 14.7% higher than average price of previous purchases. This sale made a profit of EUR 24,236 (USD $28,213) The average price that the ETF previously sold SRT3.DE share for is EUR 224.503 so the ETF has sold 759 shares on 2025-12-09 at a higher price than the previous selling average. |
| ORNBV.HE - Orion Oyj | SELL | -3,168 @ EUR 60.9 | EUR -192,931 | The ETF sold 3168 shares of ORNBV.HE on 2025-12-09. The shares were previously bought for an average price of EUR 59.669. The Orion Oyj shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of EUR 3,900 (USD $4,540) The average price that the ETF previously sold ORNBV.HE share for is EUR 54.5047 so the ETF has sold 3168 shares on 2025-12-09 at a higher price than the previous selling average. |
| ERF.PA - Eurofins Scientific SE | SELL | -3,432 @ EUR 56.74 | EUR -194,732 | The ETF sold 3432 shares of ERF.PA on 2025-12-09. The shares were previously bought for an average price of EUR 57.6515. The Eurofins Scientific SE shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of EUR 3,128 (USD $3,642) The average price that the ETF previously sold ERF.PA share for is EUR 53.6276 so the ETF has sold 3432 shares on 2025-12-09 at a higher price than the previous selling average. |
| QIA.DE - QIAGEN NV | SELL | -6,303 @ EUR 39.485 | EUR -248,874 | The ETF sold 6303 shares of QIA.DE on 2025-12-09. The shares were previously bought for an average price of EUR 39.6413. The QIAGEN NV shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 985 (USD $1,147) The average price that the ETF previously sold QIA.DE share for is EUR 38.5116 so the ETF has sold 6303 shares on 2025-12-09 at a higher price than the previous selling average. |
| FME.DE - Fresenius Medical Care AG | SELL | -6,402 @ EUR 39.26 | EUR -251,343 | The ETF sold 6402 shares of FME.DE on 2025-12-09. The shares were previously bought for an average price of EUR 45.9708. The Fresenius Medical Care AG shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of EUR 42,963 (USD $50,015) The average price that the ETF previously sold FME.DE share for is EUR 46.403 which is higher than the selling price of EUR 39.26 on 2025-12-09. |
| COLO-B.CO - | SELL | -3,663 @ DKK 75.5946 | DKK -276,903 | The ETF sold 3663 shares of COLO-B.CO on 2025-12-09. The shares were previously bought for an average price of DKK 83.2028. The shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of DKK 27,869 (USD $4,344) The average price that the ETF previously sold COLO-B.CO share for is DKK 87.3518 which is higher than the selling price of DKK 75.5946 on 2025-12-09. |
| STMN.SW - | SELL | -3,234 @ CHF 97.3509 | CHF -314,833 | The ETF sold 3234 shares of STMN.SW on 2025-12-09. The shares were previously bought for an average price of CHF 109.888. The shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 40,545 (USD $50,264) The average price that the ETF previously sold STMN.SW share for is CHF 114.492 which is higher than the selling price of CHF 97.3509 on 2025-12-09. |
| SOON.SW - | SELL | -1,485 @ CHF 212.422 | CHF -315,447 | The ETF sold 1485 shares of SOON.SW on 2025-12-09. The shares were previously bought for an average price of CHF 260.436. The shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 71,301 (USD $88,392) The average price that the ETF previously sold SOON.SW share for is CHF 291.044 which is higher than the selling price of CHF 212.422 on 2025-12-09. |
| RO.SW - | SELL | -924 @ CHF 346.951 | CHF -320,583 | The ETF sold 924 shares of RO.SW on 2025-12-09. The shares were previously bought for an average price of CHF 304.239. The shares were sold for 14.0% higher than average price of previous purchases. This sale made a profit of CHF 39,466 (USD $48,927) The average price that the ETF previously sold RO.SW share for is CHF 300.335 so the ETF has sold 924 shares on 2025-12-09 at a higher price than the previous selling average. |
| SN.L - Smith & Nephew PLC | SELL | -23,364 @ GBP 14.3106 | GBP -334,353 | The ETF sold 23364 shares of SN.L on 2025-12-09. The shares were previously bought for an average price of GBP 13.6992. The Smith & Nephew PLC shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of GBP 14,285 (USD $19,037) The average price that the ETF previously sold SN.L share for is GBP 13.0756 so the ETF has sold 23364 shares on 2025-12-09 at a higher price than the previous selling average. |
| SHL.DE - Siemens Healthineers AG | SELL | -9,834 @ EUR 43.8 | EUR -430,729 | The ETF sold 9834 shares of SHL.DE on 2025-12-09. The shares were previously bought for an average price of EUR 47.1994. The Siemens Healthineers AG shares were sold for -7.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 33,430 (USD $38,917) The average price that the ETF previously sold SHL.DE share for is EUR 48.7053 which is higher than the selling price of EUR 43.8 on 2025-12-09. |
| MRK.DE - Merck KGaA | SELL | -3,762 @ EUR 118.05 | EUR -444,104 | The ETF sold 3762 shares of MRK.DE on 2025-12-09. The shares were previously bought for an average price of EUR 117.731. The Merck KGaA shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of EUR 1,200 (USD $1,395) The average price that the ETF previously sold MRK.DE share for is EUR 123.96 which is higher than the selling price of EUR 118.05 on 2025-12-09. |
| GMAB.CO - | SELL | -1,782 @ DKK 269.12 | DKK -479,572 | The ETF sold 1782 shares of GMAB.CO on 2025-12-09. The shares were previously bought for an average price of DKK 209.088. The shares were sold for 28.7% higher than average price of previous purchases. This sale made a profit of DKK 106,977 (USD $16,674) The average price that the ETF previously sold GMAB.CO share for is DKK 197.29 so the ETF has sold 1782 shares on 2025-12-09 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -22,374 @ EUR 23.24 | EUR -519,972 | The ETF sold 22374 shares of PHIA.AS on 2025-12-09. The shares were previously bought for an average price of EUR 22.3589. The Koninklijke Philips NV shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of EUR 19,714 (USD $22,950) The average price that the ETF previously sold PHIA.AS share for is EUR 23.0875 so the ETF has sold 22374 shares on 2025-12-09 at a higher price than the previous selling average. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -12,276 @ EUR 46.96 | EUR -576,481 | The ETF sold 12276 shares of FRE.DE on 2025-12-09. The shares were previously bought for an average price of EUR 42.6885. The Fresenius SE & Co KGaA shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of EUR 52,437 (USD $61,044) The average price that the ETF previously sold FRE.DE share for is EUR 40.4069 so the ETF has sold 12276 shares on 2025-12-09 at a higher price than the previous selling average. |
| SDZ.SW - | SELL | -12,144 @ CHF 62.8263 | CHF -762,963 | The ETF sold 12144 shares of SDZ.SW on 2025-12-09. The shares were previously bought for an average price of CHF 46.9107. The shares were sold for 33.9% higher than average price of previous purchases. This sale made a profit of CHF 193,279 (USD $239,611) The average price that the ETF previously sold SDZ.SW share for is CHF 44.225 so the ETF has sold 12144 shares on 2025-12-09 at a higher price than the previous selling average. |
| GALD.SW - | SELL | -4,488 @ CHF 176.353 | CHF -791,472 | The ETF sold 4488 shares of GALD.SW on 2025-12-09. The shares were previously bought for an average price of CHF 132.226. The shares were sold for 33.4% higher than average price of previous purchases. This sale made a profit of CHF 198,042 (USD $245,514) The average price that the ETF previously sold GALD.SW share for is CHF 116.978 so the ETF has sold 4488 shares on 2025-12-09 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -3,663 @ EUR 242.2 | EUR -887,179 | The ETF sold 3663 shares of UCB.BR on 2025-12-09. The shares were previously bought for an average price of EUR 189.972. The UCB SA shares were sold for 27.5% higher than average price of previous purchases. This sale made a profit of EUR 191,311 (USD $222,716) The average price that the ETF previously sold UCB.BR share for is EUR 179.743 so the ETF has sold 3663 shares on 2025-12-09 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -14,520 @ CHF 68.3673 | CHF -992,693 | The ETF sold 14520 shares of ALC.SW on 2025-12-09. The shares were previously bought for an average price of CHF 73.8693. The shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 79,889 (USD $99,040) The average price that the ETF previously sold ALC.SW share for is CHF 78.3881 which is higher than the selling price of CHF 68.3673 on 2025-12-09. |
| BAYN.DE - Bayer AG | SELL | -28,545 @ EUR 36.31 | EUR -1,036,469 | The ETF sold 28545 shares of BAYN.DE on 2025-12-09. The shares were previously bought for an average price of EUR 25.5091. The Bayer AG shares were sold for 42.3% higher than average price of previous purchases. This sale made a profit of EUR 308,312 (USD $358,918) The average price that the ETF previously sold BAYN.DE share for is EUR 23.0312 so the ETF has sold 28545 shares on 2025-12-09 at a higher price than the previous selling average. |
| HLN.L - Haleon PLC | SELL | -258,159 @ GBP 4.0502 | GBP -1,045,596 | The ETF sold 258159 shares of HLN.L on 2025-12-09. The shares were previously bought for an average price of GBP 4.39824. The Haleon PLC shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of GBP 89,850 (USD $119,740) The average price that the ETF previously sold HLN.L share for is GBP 4.53658 which is higher than the selling price of GBP 4.0502 on 2025-12-09. |
| LONN.SW - | SELL | -2,046 @ CHF 577.116 | CHF -1,180,779 | The ETF sold 2046 shares of LONN.SW on 2025-12-09. The shares were previously bought for an average price of CHF 603.713. The shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 54,417 (USD $67,462) The average price that the ETF previously sold LONN.SW share for is CHF 586.55 which is higher than the selling price of CHF 577.116 on 2025-12-09. |
| ARGX.BR - Argenx SE | SELL | -1,782 @ EUR 768.4 | EUR -1,369,289 | The ETF sold 1782 shares of ARGX.BR on 2025-12-09. The shares were previously bought for an average price of EUR 585.67. The Argenx SE shares were sold for 31.2% higher than average price of previous purchases. This sale made a profit of EUR 325,625 (USD $379,074) The average price that the ETF previously sold ARGX.BR share for is EUR 572.246 so the ETF has sold 1782 shares on 2025-12-09 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -117,810 @ GBP 20.3882 | GBP -2,401,934 | The ETF sold 117810 shares of GSK.L on 2025-12-09. The shares were previously bought for an average price of GBP 17.4295. The GlaxoSmithKline PLC shares were sold for 17.0% higher than average price of previous purchases. This sale made a profit of GBP 348,564 (USD $464,533) The average price that the ETF previously sold GSK.L share for is GBP 17.1028 so the ETF has sold 117810 shares on 2025-12-09 at a higher price than the previous selling average. |
| EL.PA - EssilorLuxottica SA | SELL | -8,712 @ EUR 286.3 | EUR -2,494,246 | The ETF sold 8712 shares of EL.PA on 2025-12-09. The shares were previously bought for an average price of EUR 263.173. The EssilorLuxottica SA shares were sold for 8.8% higher than average price of previous purchases. This sale made a profit of EUR 201,482 (USD $234,550) The average price that the ETF previously sold EL.PA share for is EUR 259.533 so the ETF has sold 8712 shares on 2025-12-09 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -32,010 @ EUR 83.23 | EUR -2,664,192 | The ETF sold 32010 shares of SAN.PA on 2025-12-09. The shares were previously bought for an average price of EUR 87.044. The Sanofi SA shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 122,086 (USD $142,125) The average price that the ETF previously sold SAN.PA share for is EUR 91.8582 which is higher than the selling price of EUR 83.23 on 2025-12-09. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -93,357 @ DKK 40.0601 | DKK -3,739,891 | The ETF sold 93357 shares of NOVO-B.CO on 2025-12-09. The shares were previously bought for an average price of DKK 54.3016. The Novo Nordisk A/S shares were sold for -26.2% lower than average price of previous purchases. This resulted in an overall loss of DKK 1,329,544 (USD $207,230) The average price that the ETF previously sold NOVO-B.CO share for is DKK 55.5212 which is higher than the selling price of DKK 40.0601 on 2025-12-09. |
| NOVN.SW - | SELL | -55,110 @ CHF 113.825 | CHF -6,272,896 | The ETF sold 55110 shares of NOVN.SW on 2025-12-09. The shares were previously bought for an average price of CHF 104.297. The shares were sold for 9.1% higher than average price of previous purchases. This sale made a profit of CHF 525,088 (USD $650,908) The average price that the ETF previously sold NOVN.SW share for is CHF 101.126 so the ETF has sold 55110 shares on 2025-12-09 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -20,361 @ CHF 335.976 | CHF -6,840,807 | The ETF sold 20361 shares of ROG.SW on 2025-12-09. The shares were previously bought for an average price of CHF 288.914. The shares were sold for 16.3% higher than average price of previous purchases. This sale made a profit of CHF 958,229 (USD $1,187,936) The average price that the ETF previously sold ROG.SW share for is CHF 284.762 so the ETF has sold 20361 shares on 2025-12-09 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -44,946 @ GBP 155.421 | GBP -6,985,552 | The ETF sold 44946 shares of AZN.L on 2025-12-09. The shares were previously bought for an average price of GBP 132.331. The AstraZeneca PLC shares were sold for 17.4% higher than average price of previous purchases. This sale made a profit of GBP 1,037,803 (USD $1,383,103) The average price that the ETF previously sold AZN.L share for is GBP 129.414 so the ETF has sold 44946 shares on 2025-12-09 at a higher price than the previous selling average. |